Characterization of reduced and oxidized dopamine and 3,4- dihydrophenylacetic acid, on brain mitochondrial electron transport chain activities

Biochimica et Biophysica Acta - Bioenergetics

Volumn 1807, Issue 7, 2011, Pages 819-828

  Gautam, Alpa H ^a,b   Zeevalk, Gail D ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Brain; Catechol; Mitochondrion; Neurodegeneration; Neuron; Parkinson's

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; CATALASE; CYTOCHROME C OXIDASE; DOPAMINE; GLUTATHIONE; QUINONE DERIVATIVE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE (UBIQUINONE); SUPEROXIDE DISMUTASE; UBIQUINOL CYTOCHROME C REDUCTASE;

ANIMAL CELL; ARTICLE; BRAIN MITOCHONDRION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINE UPTAKE; DOSE TIME EFFECT RELATION; ENERGY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; IC 50; MITOCHONDRIAL ENERGY TRANSFER; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN BINDING; RAT; SPECTROPHOTOMETRY;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BRAIN; DOPAMINE; ELECTRON TRANSPORT; ELECTRON TRANSPORT CHAIN COMPLEX PROTEINS; GLUTATHIONE; HUMANS; MITOCHONDRIA; MULTIENZYME COMPLEXES; NADH, NADPH OXIDOREDUCTASES; OXIDATION-REDUCTION; PARKINSON DISEASE;

RATTUS;

EID: 79956088518     PISSN: 00052728     EISSN: 18792650     Source Type: Journal    
DOI: 10.1016/j.bbabio.2011.03.013     Document Type: Article

References (33)

1. G. Cohen, and N. Kessler Monoamine oxidase and mitochondrial respiration J. Neurochem. 73 1999 2310 2315
2. L.Y. Moy, G.D. Zeevalk, and P.K. Sonsalla Role for dopamine in malonate-induced damage in vivo in striatum and in vitro in mesencephalic cultures J. Neurochem. 74 2000 1656 1665 (Pubitemid 30163988)
3. S.B. Berman, and T.G. Hastings Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease J. Neurochem. 73 1999 1127 1137 (Pubitemid 29395471)
4. B. Halliwell, J.M.C. Gutteridge, Free radicals in biology and medicine, Clarendon Press, Oxford, 1989, pp. 96-98.
5. T.G. Hastings Enzymatic oxidation of dopamine: the role of prostaglandin H synthase J. Neurochem. 64 1995 919 924
6. Y. Xu, A.H. Stokes, R. Roskoski Jr., and K.E. Vrana Dopamine, in the presence of tyrosinase, covalently modifies and inactivates tyrosine hydroxylase J. Neurosci. Res. 54 1998 691 697 (Pubitemid 28546072)
7. A.H. Stokes, T.G. Hastings, and K.E. Vrana Cytotoxic and genotoxic potential of dopamine J. Neurosci. Res. 55 1999 659 665 (Pubitemid 29173480)
8. D.G. Graham Oxidative Pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones Mol. Pharmacol. 14 1978 633 643
9. F. Zhang, and G. Dryhurst Oxidation of dopamine: Possible insights into the age-dependent loss of dopaminergic nigrostriatal neurons Bioorg. Chem. 21 1993 392 410 (Pubitemid 24026003)
10. T.J. Montine, M.J. Picklo, V. Amarnath, W.O. Whetsell Jr., and D.G. Graham Neurotoxicity of endogenous cysteinylcatechols Exp. Neurol. 148 1997 26 33 (Pubitemid 127445111)
11. E. Rosengren, E. Linder-Eliasson, and A. Carlsson Detection of 5-S-cysteinyl-dopamine in human brain J. Neural Transm. 63 1985 247 253
12. T.G. Hastings, D.A. Lewis, and M.J. Zigmond Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections Proc. Natl. Acad. Sci. U. S. A. 93 1996 1956 1961 (Pubitemid 26079862)
13. M.F. Beal Mitochondria, oxidative damage and inflammation in Parkinson's disease Ann. N. Y. Acad. Sci. 991 2003 120 131 (Pubitemid 36793808)
14. W.D. Parker, S.J. Boyson, and J.K. Parks Abnormalities of the electron transport chain in idiopathic Parkinson's disease Ann. Neurol. 26 1989 719 733
15. A.H. Schipira, J.M. Cooper, D. Dexter, J.B. Clark, P. Jenner, and C.D. Marsden Complex I deficiency in Parkinson's disease J. Neurochem. 54 1990 823 827
16. R.H. Haas, F. Nasirian, K. Nakano, D. Ward, M. Pay, R. Hill, and C.W. Shults Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease Ann. Neurol. 37 1995 714 722
17. Y. Mizuno, S. Matsuda, H. Yoshino, H. Mori, and S.I. Ikebe An immunohistochemical study on alpha-ketoglutarate dehydrogenase complex in Parkinson's disease Ann. Neurol. 35 1994 204 210
18. 2 and hydroxyl radicals but not glutathione-protein-mixed disulfides J. Neurochem. 82 2002 66 74 (Pubitemid 34755250)
19. M.R. Gluck, and G.D. Zeevalk Inhibition of brain mitochondrial respiration by dopamine and its metabolites: implications for Parkinson's disease and catecholamine-associated diseases J. Neurochem. 91 2004 788 795 (Pubitemid 39507355)
20. N. Morikawa, Y. Nakagawa-Hattori, and Y. Mizuno Effect of dopamine, dimethoxyphenylethylamine, papaverine and related compounds on mitochondrial respiration and complex I activity J. Neurochem. 66 1996 1174 1181 (Pubitemid 26065915)
21. D. Ben-Shachar, R. Zuk, and Y. Glinka Dopamine neurotoxicity: inhibition of mitochondrial respiration J. Neurochem. 64 1995 718 723
22. D. Ben-Shachar, R. Zuk, H. Gazawi, and P. Ljubuncic Dopamine neurotoxicity involves mitochondrial complex I inhibition: implications to dopamine-related neuropsychiatric disorders Biochem. Pharmacol. 67 2004 1965 1974 (Pubitemid 38591384)
23. J.B. Clark, and W.J. Nicklas Metabolism of rat brain mitochondria: preparation and characterization J. Biol. Chem. 245 1970 4724 4731
24. M. Sugumaran, H. Dali, and H. Semensi Mechanistic studies on tyrosine-catalyzed oxidative decarboxylation of 3,4-dihydroxymenedelic acid J. Biochem. 281 1992 353 357
25. C.I. Ragan, M.T. Wilson, V.M. Darley-Usmar, P.N. Lowe, Subfractionation of mitochondria and isolation of the proteins of oxidative phosphorylation. In: R.M. Darley-Usmar, D. Rickwood, M.T. Wilson (Eds.), Mitochondria: a practical approach, Oxford, England: IRL Press, pp 79-113.
26. M.A. Birch-Machin, H.L. Briggs, A.A. Saborido, L.A. Bindoff, and D.M. turnbull An evaluation of measurement of the activities of complexes I-IV in the respiratory chain of human skeletal muscle mitochondria Biochem. Med. Metab. Biol. 51 1994 35 42 (Pubitemid 24174862)
27. S. Krahenbuhl, M. Chang, E.P. Brass, and C.L. Hoppel Decreased activities of ubiquinol: ferricytochrome c oxidoreductase (complex III) and ferrocytochrome c: oxygen oxidoreductase (complex IV) in liver mitochondria from rats with hydroxycabalamin[c-lactam]-induced methylmalonic aciduria J. Biol. Chem. 266 1991 20998 21003 (Pubitemid 21908564)
28. 3H]dopamine: impact of ascorbic acid and glutathione J. Neurochem. 63 1994 1126 1132 (Pubitemid 24266628)
29. F.H. Khan, T. Sen, A.K. Maiti, S. Jana, U. Chatterjee, and S. Chakrabarti Inhibition of rat brain mitochondria electron transport chain activity by dopamine oxidation products during extended in vitro incubation: implications for Parkinson's disease Biochim. Biophys. Acta 1741 2005 65 74 (Pubitemid 40824991)
30. S. Jana, A. Kumar, M. Maria, B. Bagha, K. Banerjeea, A. Dasa, A. Royb, and S. Chakrabartia Dopamine but not 3,4-dihydroxyphenylacetic acid (DOPAC) inhibits brain respiratory chain activity by autooxidation and mitochondria catalyzed oxidation to quinone products: implications in Parkinson's disease Brain Res. 1139 2007 195 200 (Pubitemid 46321531)
31. V.S. van Laar, A.A. Dukes, M. Cascio, and T.G. Hastings Proteomic identification of dopamine-conjugated proteins from isolated rat brain mitochondria and SH-SY5Y cells Neurobiol. Dis. 34 2008 487 500
32. J. Llopis, J.M. McCaffery, A. Miyawaki, M.G. Farquhar, and R.Y. Tsein Measurement of cytosolic, mitochondrial and golgi pH in single living cells with green fluorescent protein Proc. Natl. Acad. Sci. U. S. A. 95 1998 6803 6808 (Pubitemid 28278061)
33. E.V. Mosharov, L.W. Gong, B. Khanna, D. Sulzer, and M. Lindau Intracellular patch electrochemistry: regulation of cytosolic catecholamines in chromaffin cells J. Neurosci. 23 2003 5835 5845 (Pubitemid 36807863)